Global Health Limited (BOM:543654)
India
· Delayed Price · Currency is INR 1,131.95
-31.05 (-2.67%)
At close: Jun 20, 2025
Global Health Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
| Operating Revenue | 36,923 | 32,751 | 27,099 | 21,673 | 14,467 | Upgrade
|
| Other Revenue | - | - | - | 51.68 | 51.68 | Upgrade
|
| Revenue | 36,923 | 32,751 | 27,099 | 21,725 | 14,519 | Upgrade
|
| Revenue Growth (YoY) | 12.74% | 20.86% | 24.74% | 49.63% | -4.37% | Upgrade
|
| Cost of Revenue | 17,042 | 15,584 | 13,344 | 11,667 | 8,589 | Upgrade
|
| Gross Profit | 19,881 | 17,167 | 13,755 | 10,057 | 5,930 | Upgrade
|
| Selling, General & Admin | 4,973 | 5,183 | 4,213 | 2,920 | 388.82 | Upgrade
|
| Other Operating Expenses | 6,137 | 3,666 | 3,123 | 2,461 | 3,472 | Upgrade
|
| Operating Expenses | 13,048 | 10,849 | 8,911 | 6,711 | 5,146 | Upgrade
|
| Operating Income | 6,833 | 6,318 | 4,844 | 3,346 | 784.68 | Upgrade
|
| Interest Expense | -652.59 | -725.39 | -774.64 | -789.56 | -671.02 | Upgrade
|
| Interest & Investment Income | - | 596.78 | 355.36 | 167.22 | 177.59 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -19.19 | -44.36 | 13.62 | -20.81 | Upgrade
|
| Other Non Operating Income (Expenses) | 790.97 | -3.9 | 20.21 | 41.6 | 36.82 | Upgrade
|
| EBT Excluding Unusual Items | 6,972 | 6,166 | 4,400 | 2,779 | 307.26 | Upgrade
|
| Merger & Restructuring Charges | -498.96 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 8.2 | -6.77 | 2.94 | 8.63 | Upgrade
|
| Asset Writedown | - | - | - | - | -12.58 | Upgrade
|
| Other Unusual Items | - | 96.84 | 99.41 | 23.38 | 21.35 | Upgrade
|
| Pretax Income | 6,473 | 6,271 | 4,493 | 2,806 | 324.66 | Upgrade
|
| Income Tax Expense | 1,659 | 1,490 | 1,232 | 843.59 | 36.58 | Upgrade
|
| Earnings From Continuing Operations | 4,813 | 4,781 | 3,261 | 1,962 | 288.07 | Upgrade
|
| Minority Interest in Earnings | 1.19 | 1.34 | - | - | - | Upgrade
|
| Net Income | 4,814 | 4,782 | 3,261 | 1,962 | 288.07 | Upgrade
|
| Net Income to Common | 4,814 | 4,782 | 3,261 | 1,962 | 288.07 | Upgrade
|
| Net Income Growth | 0.68% | 46.65% | 66.20% | 581.07% | -20.70% | Upgrade
|
| Shares Outstanding (Basic) | 269 | 269 | 259 | 252 | 251 | Upgrade
|
| Shares Outstanding (Diluted) | 269 | 269 | 259 | 252 | 252 | Upgrade
|
| Shares Change (YoY) | 0.02% | 3.52% | 2.81% | 0.13% | 0.20% | Upgrade
|
| EPS (Basic) | 17.92 | 17.80 | 12.58 | 7.78 | 1.15 | Upgrade
|
| EPS (Diluted) | 17.92 | 17.80 | 12.57 | 7.77 | 1.14 | Upgrade
|
| EPS Growth | 0.67% | 41.61% | 61.78% | 581.58% | -20.83% | Upgrade
|
| Free Cash Flow | 1,072 | 3,335 | 4,085 | 367.87 | 960.32 | Upgrade
|
| Free Cash Flow Per Share | 3.99 | 12.42 | 15.74 | 1.46 | 3.81 | Upgrade
|
| Dividend Per Share | 0.500 | - | - | - | - | Upgrade
|
| Gross Margin | 53.84% | 52.42% | 50.76% | 46.29% | 40.84% | Upgrade
|
| Operating Margin | 18.51% | 19.29% | 17.87% | 15.40% | 5.40% | Upgrade
|
| Profit Margin | 13.04% | 14.60% | 12.03% | 9.03% | 1.98% | Upgrade
|
| Free Cash Flow Margin | 2.90% | 10.18% | 15.08% | 1.69% | 6.61% | Upgrade
|
| EBITDA | 8,771 | 7,828 | 6,188 | 4,483 | 1,843 | Upgrade
|
| EBITDA Margin | 23.75% | 23.90% | 22.83% | 20.63% | 12.70% | Upgrade
|
| D&A For EBITDA | 1,937 | 1,511 | 1,344 | 1,136 | 1,058 | Upgrade
|
| EBIT | 6,833 | 6,318 | 4,844 | 3,346 | 784.68 | Upgrade
|
| EBIT Margin | 18.51% | 19.29% | 17.87% | 15.40% | 5.40% | Upgrade
|
| Effective Tax Rate | 25.64% | 23.77% | 27.42% | 30.07% | 11.27% | Upgrade
|
| Revenue as Reported | 37,714 | 33,498 | 27,592 | 22,058 | 14,782 | Upgrade
|
| Advertising Expenses | - | 291.85 | 249.07 | 31.18 | 23.88 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.